Have a personal or library account? Click to login
The use of ex vivo ovary culture for assessment of alterations in steroidogenesis following neonatal exposure to poly(ethylene glycol)-block-polylactide methyl ether or titanium dioxide nanoparticles in Wistar rats Cover

The use of ex vivo ovary culture for assessment of alterations in steroidogenesis following neonatal exposure to poly(ethylene glycol)-block-polylactide methyl ether or titanium dioxide nanoparticles in Wistar rats

Open Access
|Feb 2020

References

  1. Alaee S, Ilani M. Effect of titanium dioxide nanoparticles on male and female reproductive systems. J Adv Med Sci Appl Technol 3, 3–8, 2017.10.18869/nrip.jamsat.3.1.3
  2. Arora S, Rajwade JM, Paknikar KM. Nanotoxicology and in vitro studies: the need of the hour. Toxicol Appl Pharmacol 258, 151–165, 2012.10.1016/j.taap.2011.11.01022178382
  3. Casalini T, Rossi F, Castrovinci A, Perale G. A perspective on polylactic acid-based polymers use for nanoparticles synthesis and applications. Front Bioeng Biotechnol 7, 259, 2019.10.3389/fbioe.2019.00259679755331681741
  4. Das J, Choi YJ, Song H, Kim JH. Potential toxicity of engineered nanoparticles in mammalian germ cells and developing embryos: Treatment strategies and anticipated applications of nanoparticles in gene delivery. Hum Reprod Update 22, 588–619, 2016.2738535910.1093/humupd/dmw02027385359
  5. Cho H, Gao J, Kwon GS. PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery. J Control Release 240, 191–201, 2016.10.1016/j.jconrel.2015.12.015490959026699425
  6. De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3, 133–149, 2008.10.2147/IJN.S596
  7. Du JZ, Tang LY, Song WJ, Shi Y, Wang J. Evaluation of polymeric micelles from brush polymer with poly(ε-caprolactone)-b-poly(ethyleneglycol) side chains as drug carrier. Biomacromolecules 10, 2169–2174, 2009.10.1021/bm900345m19722555
  8. Dvorakova M, Rollerova E, Scsukova S, Bujnakova Mlynarcikova A, Laubertova L, Zitnanova I. Effect of neonatal exposure to poly(ethylene glycol)-block-poly(lactic acid) nanoparticles on oxidative state in infantile and adult female rats. Oxid Med Cell Longev 2017, 7430435, 2017.10.1155/2017/7430435561088429081892
  9. Ferrandina G, Corrado G, Licameli A, Lorusso D, Fuoco G, Pisconti S, Scambia G. Pegylated liposomal doxorubicin in the management of ovarian cancer. Ther Clin Risk Manag 6, 463–483, 2010.10.2147/TCRM.S3348295248620957139
  10. Gao G, Ze Y, Li B, Zhao X, Zhang T, Sheng L, Hu R, Gui S, Sang X, Sun Q, Cheng J, Cheng Z, Wang L, et al. Ovarian dysfunction and gene-expressed characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles. J Hazard Mater 243, 19–27, 2012.10.1016/j.jhazmat.2012.08.04923131501
  11. Geraets L, Oomen AG, Krystek P, Jacobsen NR, Wallin H, Laurentie M, Verharen HW, Brandon EF, de Jong WH. Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Part Fibre Toxicol 11, 30, 2014.10.1186/1743-8977-11-30
  12. Grande F, Tucci P. Titanium dioxide nanoparticles: a risk for human health? Mini Rev Med Chem 16, 762–769, 2016.10.2174/1389557516666160321114341
  13. Hong FS, Yu XH, Wu N, Zhang YQ. Progress of in vivo studies on the systemic toxicities induced by titanium dioxide nanoparticles. Toxicol Res 6, 115–133, 2017.10.1039/C6TX00338A
  14. Hou CC, Zhu JQ. Nanoparticles and female reproductive system: how do nanoparticles affect oogenesis and embryonic development. Oncotarget 8, 109799–109817, 2017.2931265010.18632/oncotarget.19087
  15. Iavicoli I, Leso V, Fontana L, Bergamaschi A. Toxicological effects of titanium dioxide nanoparticles: a review of in vitro mammalian studies. Eur Rev Med Pharmacol Sci 15, 481–508, 2011.21744743
  16. Iavicoli I, Leso V, Bergamaschi A. Toxicological effects of titanium dioxide nanoparticles: a review of in vivo studies. J Nanomater 2012, 964381, 2012.10.1155/2012/964381
  17. Iavicoli I, Fontana L, Leso V, Bergamaschi A. The effects of nanomaterials as endocrine disruptors. Int J Mol Sci 14, 16732–16801, 2013.2394963510.3390/ijms140816732
  18. Kolena J, Scsukova S, Jezova M, Furdova J, Tatara M, Jasem P. Effect of phospholipids on the reconstitution and thermal stability of delipidated rat ovarian luteinizing hormone/human chorionic gonadotropin receptors in proteoliposomes. Mol Cell Endocrinol 113, 53–60, 1995.10.1016/0303-7207(95)03610-J
  19. Larson JK, Carvan MJ 3rd, Hutz RJ. Engineered nanomaterials: an emerging class of novel endocrine disruptors. Biol Reprod 91, 20, 2014.10.1095/biolreprod.113.116244443496124899576
  20. Moritz M, Gezske-Moritz M. Recent developments in the application of polymeric nanoparticles as drug carriers. Adv Clin Exp Med 24, 749–758, 2015.10.17219/acem/318022676862426768624
  21. Newbold RR, Jefferson WN, Padilla-Banks E. Long-term adverse effects of the neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol 24, 253–258, 2007.1780419410.1016/j.reprotox.2007.07.006204338017804194
  22. Philbrook NA, Winn LM, Afrooz AR, Saleh NB, Walker VK. The effect of TiO(2) and Ag nanoparticles on reproduction and development of Drosophila melanogaster and CD-1 mice. Toxicol Appl Pharmacol 257, 429–436, 2011.10.1016/j.taap.2011.09.02722005274
  23. Picut CA, Dixon D, Simons ML, Stump DG, Parker GA, Remick AK. Postnatal ovary development in the rat: morphologic study and correlation of morphology to neuroendocrine parameters. Toxicol Pathol 43, 343–353, 2015.2510757410.1177/0192623314544380432098525107574
  24. Rollerova E, Jurcovicova J, Mlynarcikova A, Sadlonova I, Bilanicova D, Wsolova L, Kiss A, Kovriznych J, Kronek J, Ciampor F, Vavra I, Scsukova S. Delayed adverse effects of neonatal exposure to polymeric nanoparticle poly(ethylene glycol)-block-polylactide methyl ether on hypothalamic-pituitary-ovarian axis development and function in Wistar rats. Reprod Toxicol 57, 165–175, 2015a.10.1016/j.reprotox.2015.07.07226193689
  25. Rollerova E, Tulinska J, Liskova A, Kuricova M, Kovriznych J, Mlynarcikova A, Kiss A, Scsukova S. Titanium dioxide nanoparticles: some aspects of toxicity/focus on the development. Endocr Regul 49, 97–112, 2015b.10.4149/endo_2015_02_9725960011
  26. Rompelberg C, Heringa MB, van Donkersgoed G, Drijvers J, Roos A, Westenbrink S, Peters R, van Bemmel G, Brand W, Oomen AG. Oral intake of added titanium dioxide and its nanofraction from food products, food supplements and toothpaste by the Dutch population. Nanotoxicology 10, 1404–1414, 2016.2761900710.1080/17435390.2016.122245727619007
  27. Sebekova K, Dusinska M, Simon Klenovics K, Kollarova R, Boor P, Kebis A, Staruchova M, Vlkova B, Celec P, Hodosy J, Baciak L, Tuskova R, Beno M, Tulinska J, Pribojova J, Bilanicova D, Pojana G, Marcomini A, Volkovova K. Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats. Nanotoxicology 8, 142–157, 2014.10.3109/17435390.2012.76314723272807
  28. Semete B, Booysen L, Lemmer Y, Kalombo L, Katata L, Verschoor J, Swai HS. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine 6, 662–671, 2010.10.1016/j.nano.2010.02.0022023091220230912
  29. Shen S, Du XJ, Liu J, Sun R, Zhu YH, Wang J. Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy. J Control Release 208, 14–24, 2015.10.1016/j.jconrel.2014.12.04325575864
  30. Shi HB, Magaye R, Castranova V, Zhao JS. Titanium dioxide nanoparticles: A review of current toxicological data. Part Fibre Toxicol 10, 15, 2013.10.1186/1743-8977-10-15363714023587290
  31. Shin HC, Alani AWG, Rao DA, Rockich NC, Kwon GS. Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. J Control Release 140, 293–300, 2009.10.1016/j.jconrel.2009.04.024278785719409432
  32. Shin HC, Cho H, Lai TC, Kozak KR, Kolesar JM, Kwon GS. Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D,L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygel danamycin, and rapamycin. J Control Release 163, 93–99, 2012.10.1016/j.jconrel.2012.04.024342261222549011
  33. Scsukova S, Mlynarcikova A, Kiss A, Rollerova E. Effect of polymeric nanoparticle poly(ethylene glycol)-block-poly(lactic acid) (PEG-b-PLA) on in vitro luteinizing hormone release from anterior pituitary cells of infantile and adult female rats. Neuro Endocrinol Lett 36, 88–94, 2015.26757115
  34. Scsukova S, Bujnakova Mlynarcikvoa A, Kiss A, Rollerova E. Adverse eff ects of polymeric nanoparticle poly(ethylene glycol)- block-polylactide methyl ether (PEG-b-PLA) on steroid hormone secretion by porcine granulosa cells. Endocr Regul 51, 96–104, 2017.10.1515/enr-2017-000928609289
  35. Stefansdottir A, Fowler PA, Powles-Glover N, Anderson RA, Spears N. Use of ovary culture techniques in reproductive toxicology. Reprod Toxicol 49, 117–135, 2014.10.1016/j.reprotox.2014.08.00125150138
  36. Tassinari R, Cubadda F, Moracci G, Aureli F, D’Amato M, Valeri M, De Baerardis B, Raggi A, Mantovani A, Passeri D, Rossi M, Maranghi F. Oral, short-term exposure to titanium dioxide nanoparticles in Sprague-Dawley rat: focus on reproductive and endocrine systems and spleen. Nanotoxicology 8, 654–662, 2014.2383434410.3109/17435390.2013.82211423834344
  37. Taylor U, Barchanski A, Kues W, Barcikowski S, Rath D. Impact of metal nanoparticles on germ cell viability and functionality. Reprod Domest Anim 47, 359–368, 2012.10.1111/j.1439-0531.2012.02099.x2282739322827393
  38. Wang A, Marinakos SM, Badireddy AR, Powers ChM, Keith AH. Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity, WIREs Nanomed Nanobiotechnol 5, 430–448, 2013.10.1002/wnan.122923661551
  39. Wang N, Wang Z, Nie S, Song L, He T, Yang S, Yang X, Yi C, Wu Q, Gong C. Biodegradable polymeric micelles co-encapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo. Int J Nano-medicine 12, 1499–1514, 2017.10.2147/IJN.S124843532814128260895
  40. Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 46, 2242–2250, 2012.10.1021/es204168d328846322260395
  41. Xiao RZ, Zeng ZW, Zhou GL, Wang JJ, Li FZ, Wang AM. Recent advances in PEG-PLA block copolymer nanoparticles. Int J Nanomedicine 5, 1057–1065, 2010.10.2147/IJN.S14912300020521170353
  42. Xiao L, Xiong X, Sun X, Zhu Y, Yang H, Chen H, Gan L, Xu H, Yang X. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials 32, 5148–5157, 2011.10.1016/j.biomaterials.2011.03.07121546083
  43. Zhang X, Li W, Yang Z. Toxicology of nanosized titanium dioxide: an update. Arch Toxicol 89, 2207–2217, 2015.10.1007/s00204-015-1594-626391178
  44. Zhao X, Ze Y, Gao G, Sang X, Li B, Gui S, Sheng L, Sun Q, Cheng J, Cheng Z, Hu R, Wang L, Hong F. Nanosized TiO2-induced reproductive system dysfunction and its mechanism in female mice. PLoS ONE 8, e59378, 2013.10.1371/journal.pone.0059378361500823565150
DOI: https://doi.org/10.2478/enr-2020-0007 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Language: English
Page range: 53 - 63
Published on: Feb 1, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Sona Scsukova, Alzbeta Bujnakova Mlynarcikova, Eva Rollerova, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.